Related Experiment Videos
Altered cerebral energy utilization in late life depression
I A Cook1, A F Leuchter, S H Uijtdehaage
1Quantitative EEG Laboratory, Neuropsychiatric Institute and Hospital, UCLA School of Medicine, University of California, Los Angeles, USA. icook@ucla.edu
Journal of Affective Disorders
|June 3, 1998
Summary
Late life depression shows altered brain energy use, detected by cordance (a quantitative EEG measure). Treatment normalizes these cerebral energy utilization patterns, suggesting cordance sensitivity to interventions.
Area of Science:
- Geriatric Psychiatry
- Neuroscience
- Quantitative Electroencephalography (qEEG)
Background:
- Late-life depression is associated with changes in global and regional cerebral energy utilization.
- Understanding these neurophysiological alterations is crucial for effective diagnosis and treatment.
Purpose of the Study:
- To investigate cerebral energy utilization in late-life depression using cordance.
- To determine if cordance can differentiate between unmedicated depressed individuals and controls.
- To assess the impact of treatment on cordance patterns in late-life depression.
Main Methods:
- Quantitative EEG (qEEG) was used to measure cordance, a marker of cerebral energy utilization.
- Twenty-seven subjects with late-life depression (unmedicated and medicated) and 27 matched controls were studied.
- Cordance patterns were analyzed to identify differences in brain energy metabolism.
Main Results:
- Significant global and focal (anterior, centrotemporal) differences in theta-band cordance were observed between unmedicated depressed subjects and controls.
- Depressed subjects undergoing treatment exhibited cordance patterns comparable to those of control subjects.
- These findings suggest that cordance can detect altered cerebral physiology in depression.
Conclusions:
- Pre-treatment disturbances in cerebral energy utilization, both diffuse and focal, are detectable by cordance in late-life depression.
- Cordance may serve as a sensitive biomarker for altered brain physiology in depression.
- The measure shows potential sensitivity to treatment interventions, indicating its utility in monitoring therapeutic response.